Newsroom | 41728 results

OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda (TSE:4502/NYSE:TAK) today announced new interim data from the Phase 1b, open-label, proof-of-concept study of subcutaneous mezagitamab (TAK-079), an anti-CD38 monoclonal antibody with disease-modifying potential, in primary immunoglobulin A (IgA) nephropathy. Data from the study showed that kidney function (eGFR) remained stable in patients with IgA nephropathy through Week 96 – up to 18 months after the last mezagitamab dose.1 The result...

WINTER PARK, Fla.--(BUSINESS WIRE)--Humata Health, the leader in AI-powered prior authorization technology, has been selected by the Centers for Medicare & Medicaid (CMS) as a key partner for its WISeR model, an initiative focused on safeguarding patients and protecting Medicare funds. Humata will use its proprietary technology to help build a more modern, efficient and fair clinical approval process for CMS, the single largest payer for healthcare in the U.S. The WISeR model — which launch...

DUBLIN--(BUSINESS WIRE)--The "Canada Fair-Market Value Compensation Rates for Endocrinology KOLs" report has been added to ResearchAndMarkets.com's offering. This report presents fair-market value compensation rates for Canadian KOLs in endocrinology, by percentiles, with averages, for four (4) levels of Thought Leader influences (rare, international, national, and local). These defensible market-based rate data are built directly from industry compensation paid to Healthcare Practitioners (HCP...

BELO HORIZONTE, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, today announced that the Secretary of Regulation and Supervision of Higher Education of the Ministry of Education (“MEC”) authorized the increase of 100 medical seats of ITPAC Porto Nacional – Instituto Tocantinense Presidente Antonio Carlos Porto S.A. (AFYA Faculdade de Ciências Médicas Bragança), in t...

MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced pivotal clinical validation results from the ALTUS study (NCT: 05064553). The prospective, head-to-head trial demonstrated that the company’s Oncoguard® Liver blood test delivers superior early-stage and overall sensitivity for hepatocellular carcinoma (HCC) — the most common form of liver cancer — compared to the current standard of care.1,2 These fi...

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced its participation in the Jefferies 2025 London Healthcare Conference. Peter Caldini, Chief Executive Officer, and Raj Denhoy, Chief Financial Officer, are scheduled to present in a fireside chat on Wednesday, November 19, 2025 at 8:30 a.m. GMT. A live webcast of the...

DUBLIN--(BUSINESS WIRE)--The "Germany Fair-Market Value Compensation Rates for Hematology KOLs" report has been added to ResearchAndMarkets.com's offering. This report presents fair-market value (FMV) hourly and half-day compensation rates for German KOLs - Hematology, report presents fair-market value (FMV) hourly and half-day compensation rates for US-based KOLs in Hematology, by percentiles, with averages, for four (4) levels of Thought Leader influences (rare, international, national and lo...

EL MONTE, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent,” or the “Company”), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced financial results for its third quarter ended September 30, 2025. Third Quarter 2025 Results: Revenue of $84.1 million, growing 17% year-over-year GAAP loss of $6.6 million, or ($0.21) per share Non-GAAP income of $4.5 million, or $0.14 per share Adjusted EBI...

MURFREESBORO, Tenn.--(BUSINESS WIRE)--National HealthCare Corporation (NYSE American: NHC), the nation's oldest publicly traded senior health care company, announced today net operating revenues for the quarter ended September 30, 2025 totaled $382,661,000 compared to $340,198,000 for the quarter ended September 30, 2024, an increase of 12.5%. The increase in net operating revenues for the third quarter of 2025 compared to the third quarter of 2024 was due to an 8.7% increase in same-facility n...

--(BUSINESS WIRE)--UNH Board Authorizes Payment of Quarterly Dividend...